Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Cash from Operations (2020 - 2025)

Historic Cash from Operations for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to -$1.2 million.

  • RxSight's Cash from Operations fell 28261.54% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.7 million, marking a year-over-year increase of 1111.16%. This contributed to the annual value of -$16.9 million for FY2024, which is 5925.76% up from last year.
  • According to the latest figures from Q3 2025, RxSight's Cash from Operations is -$1.2 million, which was down 28261.54% from -$4.4 million recorded in Q2 2025.
  • Over the past 5 years, RxSight's Cash from Operations peaked at $650000.0 during Q3 2024, and registered a low of -$17.8 million during Q1 2023.
  • Moreover, its 5-year median value for Cash from Operations was -$8.8 million (2025), whereas its average is -$9.3 million.
  • As far as peak fluctuations go, RxSight's Cash from Operations surged by 10814.33% in 2024, and later crashed by 28261.54% in 2025.
  • RxSight's Cash from Operations (Quarter) stood at -$8.7 million in 2021, then crashed by 58.84% to -$13.9 million in 2022, then skyrocketed by 40.08% to -$8.3 million in 2023, then soared by 48.68% to -$4.3 million in 2024, then skyrocketed by 72.14% to -$1.2 million in 2025.
  • Its Cash from Operations was -$1.2 million in Q3 2025, compared to -$4.4 million in Q2 2025 and -$8.8 million in Q1 2025.